Development of a standardized commercial test to “score” patients as eligible for active surveillance

A new paper to be presented at the Genitourinary Prostate Cancer Symposium has proposed development of a standardized method to “score” whether patients are suitable candidates for initial management on active surveillance. … READ MORE …

CAPRA-S scores and projection of prostate cancer recurrence post-surgery

The University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment (CAPRA) score was initially introduced in 2005 and validated in 2006 as a pre-treatment tool that could be used to assess risk for prostate cancer recurrence after first-line treatment. … READ MORE …

How to calculate (and use) your CAPRA score

The CAPRA score — which stands for “Cancer of the Prostate Risk Assessment” score — was developed at the University of San Francisco as a method to assess risk of prostate cancer progression based on risk for metastases or prostate cancer-specific mortality. … READ MORE …